WELLINGTON MANAGEMENT GROUP LLP – Apellis Pharmaceuticals, Inc. Transaction History
WELLINGTON MANAGEMENT GROUP LLP portfolio value:
$680.09M
portfolio value
WELLINGTON MANAGEMENT GROUP LLP quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -13.73% | -1.58M shares | 158.12M | $68.3 | 9.95M |
| Q2 2022 | share | Decrease | -18.71% | -2.65M shares | -199.50M | $45.22 | 11.54M |
| Q1 2022 | share | Increase | +15.15% | 1.86M shares | 138.47M | $50.81 | 14.19M |
| Q4 2021 | share | Increase | +10.38% | 1.15M shares | 214.77M | $47.95 | 12.33M |
| Q3 2021 | share | Increase | +4.27% | 457.74K shares | -308.89M | $32.96 | 11.17M |
| Q2 2021 | share | Increase | +2.15% | 225.72K shares | 227.06M | $63.2 | 10.71M |
| Q1 2021 | share | Decrease | -0.19% | -20.00K shares | -151.01M | $42.91 | 10.48M |
| Q4 2020 | share | Increase | +0.53% | 55.30K shares | 285.70M | $57.2 | 10.50M |
| Q3 2020 | share | Increase | +0.08% | 8.29K shares | -25.75M | $30.17 | 10.45M |
| Q2 2020 | share | Increase | +0.70% | 72.51K shares | 63.25M | $32.66 | 10.44M |
| Q1 2020 | share | Increase | +140.24% | 6.05M shares | 145.67M | $26.79 | 10.37M |
| Q4 2019 | share | Increase | +18.87% | 685.39K shares | 44.70M | $30.62 | 4.31M |
| Q3 2019 | share | Decrease | -29.41% | -1.51M shares | -42.89M | $24.09 | 3.63M |
| Q2 2019 | share | Increase | +32.71% | 1.26M shares | 54.78M | $25.34 | 5.14M |
| Q1 2019 | share | Increase | +24676.16% | 3.86M shares | 75.39M | $19.5 | 3.87M |
| Q4 2018 | share | Increase | 0.00% | 15.64K shares | 206K | $13.19 | 15.64K |